Atlas Trials

"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"

Clinical trial NCT02348593 · COMPLETED

Trial details

NCT number
NCT02348593
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Narcolepsy
Start date
2015-05-01
Primary completion
2017-02-01
Enrollment
239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.